Financial Daily from THE HINDU group of publications
Saturday, Mar 18, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Regulatory Bodies & Rulings


Aurobindo gets Bristol-Myers nod for 2 ARVs

Our Bureau

Hyderabad , March 17

Aurobindo Pharma Ltd (APL) announced that Bristol-Myers Squibb Company (BMS) has given licence to market two important anti-retrovirals (ARVs) - Stavudine and Didanosine - in 49 countries, including South Africa.

In a press release here on Friday, the company said one of the objectives of the licence was to increase access of the products for the benefit of people in the treatment of HIV/AIDS.

Aurobindo has the largest number of approved products by the United States Food and Drug Administration (USFDA) for the ARV segment. The company said it continued to play an anchor role in the management of AIDS by supplying APIs (active pharmaceutical ingredients) and formulations for most of the ARVs.

The USFDA had already approved under the PEPFAR programme the ARV drug Stavudine capsules 30 mg and 40 mg and Stavudine oral solution 1 mg/ml. Further, the US drug authority had also approved the relevant API and formulation facilities of Aurobindo Pharma.

Thanking BMS for granting licence to market two ARVs, Aurobindo Pharma said it was hopeful of such gestures by various MNCs in the world to enhance the access of quality ARV generics for the benefit of people.

Related Stories:
Aurobindo HIV drug gets USFDA nod
Aurobindo gets 6 ARVs WHO pre-qualified
Aurobindo Pharma gets USFDA nod for another ARV

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Ind-Swift Labs sets up R&D centre in Mohali


Ministry to broadbase large taxpayer unit norm
Suzlon to buy Belgian co Hansen for Rs 2,511 cr
Precot Mills-Meridian Ind share swap ratio fixed at 1:2
Exim Bank to lend $5 m to Ucal Fuel arm
Aditya Birla group goes to Laos, to set up wood pulp plant
Centaur setting up unit at Pune biotech park
Lucas-TVS plans multi-location expansion
Haworth Inc inaugurates facility in Pune
Aurobindo gets Bristol-Myers nod for 2 ARVs
BPCL, Kochi Refineries plan joint venture
NTPC plans to bid for gas blocks under NELP-VI
Asia to become largest revenue earner for ICI's paint biz
Hotel Leela director steps down



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line